Envoy Medical, Inc. 8-K

What Happened

• Envoy Medical, Inc. (ticker: COCH) filed a Form 8-K on June 30, 2026 announcing the termination of its At-The-Market Offering Agreement (the “ATM Agreement”) that was originally dated January 17, 2025. The company issued a press release about the termination on June 24, 2026, which is attached to the 8-K as Exhibit 99.1. The press release information is furnished (not “filed”) under the Exchange Act.

Key Details

• ATM Agreement originally dated: January 17, 2025.
• Termination announced in a press release dated: June 24, 2026 (attached as Exhibit 99.1).
• 8-K filed with the SEC on: June 30, 2026.
• The press release is furnished and is not being treated as filed for Section 18 liability or incorporated by reference into other filings.

Why It Matters

• An ATM program is a mechanism the company can use to sell newly issued shares into the market over time to raise capital. Terminating the ATM Agreement removes this specific financing tool from Envoy Medical’s available options. For investors, that could affect the company’s near-term flexibility to raise equity capital and may influence expectations about future dilution or funding plans. The filing does not state reasons for the termination or whether a replacement financing arrangement will be pursued, so shareholders should watch for further announcements.